Vimarsana
Biggest News Aggregation in the World

Page 2 - Clinical Data Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Data Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Data Analysis Today - Breaking & Trending Today

Mothers' Diabetes Linked to ADHD in Their Children - Vimarsana News

Mothers' Diabetes Linked to ADHD in Their Children

A small increased risk of ADHD in children born to mothers with diabetes, including pregestational diabetes and gestational diabetes, has been found.

LAIAs More Effective Than Oral Antipsychotics for Schizophrenia - Vimarsana News

LAIAs More Effective Than Oral Antipsychotics for Schizophrenia

Although some clinicians are hesitant to prescribe long-acting injectables for schizophrenia, new research suggests they're superior to oral antipsychotics in preventing relapse ― and they're safer.

Sodium-Glucose Cotransporter-2 Inhibitors Decrease Risk for Pneumonia, Sepsis - Vimarsana News

Sodium-Glucose Cotransporter-2 Inhibitors Decrease Risk for Pneumonia, Sepsis

SGLT2 inhibitors were associated with a decreased risk for pneumonia and sepsis compared with DPP-4 inhibitors in patients with type 2 diabetes.

SGLT2 inhibitors may lower risk for adverse renal outcomes vs. DPP-IV inhibitors - Vimarsana News

SGLT2 inhibitors may lower risk for adverse renal outcomes vs. DPP-IV inhibitors

The use of SGLT2 inhibitors with type 2 diabetes is associated with lower risks for end-stage renal disease and acute renal failure compared with DPP-IV inhibitor use, according to study findings from Hong Kong. “DPP-IV inhibitors and SGLT2 inhibitors are commonly used second-line antidiabetic medications,” Ching-Lung Cheung, PhD, associate professor in the department of pharmacology

Source: healio.com
Myocarditis low after COVID-19 vaccination, but odds elevated in male teens, young adults - Vimarsana News

Myocarditis low after COVID-19 vaccination, but odds elevated in male teens, young adults

Despite low absolute rates, researchers observed elevated odds of cardiac injury among male adolescents and young adults after messenger RNA-based COVID-19 vaccination in a large U.S. study, as well as a smaller study in Hong Kong.Among 192.4 million vaccinated adolescents and young adults in the U.S., researchers observed 1,991 cases of myocarditis after at least one dose.

Source: healio.com